Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (281-290 of 399) with videos related to

Pageof 40
Sort By:
Leukemia|February 27, 2009
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialJ E Rubnitz, K R Crews, S Pounds, et al.
Blood|May 6, 2003
Classification of pediatric acute lymphoblastic leukemia by gene expression profilingMary E Ross, Xiaodong Zhou, Guangchun Song, et al.
Blood|June 1, 2012
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology GroupMichael R Loken, Todd A Alonzo, Laura Pardo, et al.
Leukemia & Lymphoma|September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AMLJatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Blood|February 1, 1991
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 casesC H Pui, L S Frankel, A J Carroll, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Blood|January 10, 2009
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research HospitalJeffrey E Rubnitz, Mihaela Onciu, Stanley Pounds, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Pageof 40

Showing results (281-290 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|February 27, 2009
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialJ E Rubnitz, K R Crews, S Pounds, et al.
Blood|May 6, 2003
Classification of pediatric acute lymphoblastic leukemia by gene expression profilingMary E Ross, Xiaodong Zhou, Guangchun Song, et al.
Blood|June 1, 2012
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology GroupMichael R Loken, Todd A Alonzo, Laura Pardo, et al.
Leukemia & Lymphoma|September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AMLJatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Blood|February 1, 1991
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 casesC H Pui, L S Frankel, A J Carroll, et al.
Blood|June 5, 2001
Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experienceU H Athale, B I Razzouk, S C Raimondi, et al.
Leukemia|October 6, 2000
Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.
Lancet (London, England)|March 11, 1998
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemiaE Coustan-Smith, F G Behm, J Sanchez, et al.
Blood|January 10, 2009
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research HospitalJeffrey E Rubnitz, Mihaela Onciu, Stanley Pounds, et al.
Blood|March 2, 2012
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AMLJessica A Pollard, Todd A Alonzo, Michael Loken, et al.
Pageof 40